For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period.
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.
In additional, EU is also the largest consumer of rosuvastatin calcium, about 34% of the global production was consumed in EU. China is the second producer with the market share of 28%. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55% of the total amount.
The Global Info Research report includes an overview of the development of the Rosuvastatin Calcium industry chain, the market status of Tablet (including dispersible tablet and general tablet) (Purity 98.0%, Purity 99.0%), Capsule (Purity 98.0%, Purity 99.0%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rosuvastatin Calcium.
Regionally, the report analyzes the Rosuvastatin Calcium markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rosuvastatin Calcium market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rosuvastatin Calcium market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rosuvastatin Calcium industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Purity 98.0%, Purity 99.0%).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rosuvastatin Calcium market.
Regional Analysis: The report involves examining the Rosuvastatin Calcium market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rosuvastatin Calcium market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rosuvastatin Calcium:
Company Analysis: Report covers individual Rosuvastatin Calcium manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rosuvastatin Calcium This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Tablet (including dispersible tablet and general tablet), Capsule).
Technology Analysis: Report covers specific technologies relevant to Rosuvastatin Calcium. It assesses the current state, advancements, and potential future developments in Rosuvastatin Calcium areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rosuvastatin Calcium market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rosuvastatin Calcium market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Purity 98.0%
- Purity 99.0%
- Other
Market segment by Application
- Tablet (including dispersible tablet and general tablet)
- Capsule
- Others
Major players covered
- AstraZeneca
- Teva Pharmaceutical Industries
- MSN Laboratories
- Cadila Pharmaceuticals
- LGM Pharma
- Bal Pharma
- Changzhou Pharmaceutical Factory
- Jingxin Pharm
- Zhejiang Hisun Pharmaceutical
- HEC Pharm
- Lunan Pharmaceutical
- Nanjing Frochem Tech
- Lianyungang Runzhong Pharmaceutical
- Shandong Bechem Chemicals
- CTX Life Sciences
Market segment by region, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rosuvastatin Calcium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rosuvastatin Calcium, with price, sales, revenue and global market share of Rosuvastatin Calcium from 2019 to 2024.
Chapter 3, the Rosuvastatin Calcium competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rosuvastatin Calcium breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rosuvastatin Calcium market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rosuvastatin Calcium.
Chapter 14 and 15, to describe Rosuvastatin Calcium sales channel, distributors, customers, research findings and conclusion.